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Abstract 
β-Lactam ring-containing compounds play a pivotal role in drug design and synthetic chemistry. Spirocyclic β-
lactams, representing an important β-lactam subclass, have recently attracted considerable interest with 
respect to new synthetic methodologies and pharmacological applications. The aim of this manuscript is to 
review the recent progress made in this field, covering publications disseminated between 2011 to 2018 
concerning the synthesis and application of spirocyclic β-lactams. In the first part, new approaches to the 
synthesis of spirocyclic β-lactams, including Staudinger synthesis, cyclization and transformation reactions, will 
be presented. The reactivity and biological properties of spiro-β-lactams will be described in the second and 
third part, respectively. 
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1. Introduction  
 
The β-lactam (azetidin-2-one) ring is one of the most significant azaheterocycles studied from both a synthetic 
and medicinal chemistry point of view in the last decades. Its prominence is due to the presence of the 
β-lactam core in many antibiotics (e.g., penicillins, carbapenems, monobactams and sulbactams) used in the 
fight against pathogenic bacteria. In addition to their antibacterial properties, β-lactams possess other 
pharmacological activities such as cholesterol absorption inhibition, anti-inflammation, anti-tubercular and 
anti-HIV activity.1 Over the years, β-lactams have also emerged as versatile building blocks (β-lactam synthon 
method) for the synthesis of amino acids, alkaloids and taxoids with potential biological properties.2-5 In the 
light of these excellent applications, much attention has been devoted to development of novel and more 
effective β-lactam compounds and the evaluation of their biological and synthetic potential.1,6 On the other 
hand, the overuse of β-lactam antibiotics leads to an increasing number of resistant bacterial strains. These 
new challenges have given impetus to the search for the replacement or modification of the available β-
lactam structures to meet current urgent needs.7-9 
Spirocyclic β-lactams, which contain a (small) ring spiro-fused at the C3 or C4 position of a β-lactam core 
(Figure 1), have recently been found to be eligible candidates for drug discovery. They have, for example, been 
exploited as antibacterial agents, antiviral agents and cholesterol absorption inhibitors. In that respect, 
structure-activity relationship studies have identified 3-spiro-cyclohexyl-β-lactams SCH 54016 A and SCH 
58053 B as two potential cholesterol absorption inhibitors.10 In addition, spiro-β-lactams have been used as β-
turn mimetics in peptidomimetic chemistry. It has been found that spiro-β-lactams also act as poliovirus and 
human rhinovirus 3C-proteinases inhibitors. Thus, the search for new spiro-β-lactam derivatives comprises a 
relevant research topic.10 In addition, spiro-β-lactams have been used as starting materials to prepare α- and 
β-amino acids, alkaloids, heterocycles, taxoids11 and other relevant compounds.12 In that respect, several new 
methodologies for the synthesis of spiro-β-lactams have been developed, as is evident from the many reviews 
in the field.11-13  
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As an extension of the review article by De Kimpe in 2011, this review is constructed in a similar way, 
including synthetic approaches, reactivity, and biological activities of spiro-fused azetidin-2-ones, spanning 
publications from 2011 to 2018.13  
 
 
 
Figure 1. General representation of C3 and C4 spiro-fused azetidin-2-ones. 
 
 
2. Synthesis of Spiro-fused β-lactams 
 
2.1. Cyclocondensation reactions 
The Staudinger [2+2]-cyclocondensation of ketenes and imines is the most widely used method for the 
synthesis of the β-lactam ring skeleton. Although, according to IUPAC guidelines, the term ‘cycloaddition’ can 
be used for this two-step process via zwitterionic intermediates, this method is mostly referred to as a 
cyclocondensation reaction. Spiro-fused β-lactams can also be prepared in this way employing various types of 
ketenes and imines. Depending on the ketenes and imines applied, two different types of spiro-fused azetidin-
2-ones can be synthesized. More specifically, the reaction of an acyclic ketene with a cyclic imine will furnish 
C4 spiro-fused azetidin-2-ones, whereas the reaction of a cyclic ketene with an acyclic imine will afford C3 
spiro-fused azetidin-2-ones.  
 
2.1.1. Reactions of acyclic ketenes. Jarrahpour and co-workers have explored the potential of the Staudinger 
synthesis to access new spiro-fused β-lactams. In particular, the [2+2]-cyclocondensation of imines 1, which 
were prepared from 9H-fluoren-9-one and substituted anilines with a catalytic amount of acetic acid in 
ethanol, with either phenoxyacetic acid or 9H-xanthene-9-carboxylic acid in the presence of triethylamine and 
tosyl chloride afforded spiro-β-lactams 2 or dispiro-β-lactams 3, respectively (Scheme 1). This strategy has also 
been extended to the synthesis of several bis-spiro- and bis-dispiro-β-lactams.6,14 The spiro-β-lactams 3 could 
be further converted into the corresponding NH-spiro-β-lactams in excellent yields by eluting them over a 
column packed with 10% SiO2-NaSO3, 10% CAN-SiO2 and little silica gel.
15 
 
 
Scheme 1 
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The spirocyclic indeno[1,2-b]quinoxaline β-lactams 5 and 6 were prepared by treatment of N-phenyl-11H-
indeno[1,2-b]quinoxalin-11-imine derivatives 4 with various phenoxyacetic acid derivatives in the presence of 
triethylamine and tosyl chloride in anhydrous CH2Cl2 at room temperature (Scheme 2). The diastereomeric 
ratio of 5 and 6 (50:50) was determined by the integration of the proton H-3. The structures of β-lactams 5 
and 6 were further confirmed by X-ray crystallography.16  
 
 
Scheme 2 
 
The synthesis and pharmacological evaluation of isatin-derived compounds has attracted the attention of 
many research groups.13,17-20 For example, in the course of a screening study for β-lactam compounds 
possessing antibacterial and antifungal activities, Shah and co-workers successfully synthesized a number of 
novel spiro[azetidine-2,3’-indole]-2’,4(1’H)-diones 10 and 12 by means of the Staudinger synthesis (Scheme 3). 
The preparation of imines 9 and 11 was performed by reaction between either dibromoisatin 8, which was 
obtained by treatment of isatin 7 with bromine in methanol, or isatin 7 with different primary aromatic amines 
in absolute ethanol in the presence of glacial acetic acid. Subsequently, treatment of imines 9 and 11 with 
chloroacetyl chloride in the presence of a tertiary base at 80 °C to reflux temperature led to the target spiro-β-
lactams 10 and 12. The antibacterial and antifungal activities of these spiro β-lactams were evaluated.21  
 
 
Scheme 3 
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In addition, the cyclocondensation of isatin-3-arylimine with various diazoketo esters catalyzed by 
rhodium(II) also gave rise to spiro(oxindolyl)-β-lactams.22 Recently, the Kandile group has reported the 
generation of bis-spiroazetidinone derivatives by the reaction of bis-Schiff bases, derived from 5-substituted 
isatins, with chloroacetyl chloride.23 Concurrently, Xu and co-workers have disclosed a direct asymmetric 
[2+2]-annulation reaction of simple aliphatic aldehydes with isatin-derived ketimines via N-heterocyclic 
carbene (NHC) catalysis furnishing enantioenriched spiroindole β-lactams.24 
The synthesis of spiro-fused seleno-β-lactams has been studied by using Z/E isomers of α-selenium-
substituted exocyclic imines 13 with various types of acyl chlorides, such as methoxy-, chloro-, propionyl-, 
phenyl-, cyclohexyl-, phenoxy-, and p-chlorophenoxyacetyl chloride under optimized Staudinger synthesis 
conditions (Scheme 4). The reaction of exocyclic imines 13 with acetyl chlorides 14 gave rise to spiro-β-lactams 
15 in excellent yields as mixtures of stereoisomers. The diastereomeric ratio (d.r.) of the resulting spiro-β-
lactams 15 was calculated by 1H NMR spectral analysis. It should be noted that the stereochemical outcome of 
β-lactam formation under Staudinger reaction conditions can be explained by the electronic effects of the 
substituents on the ketenes, which were generated from the corresponding acid chlorides.25  
 
 
 
Scheme 4 
 
The synthesis of new spiro-fused azetidinone-androgen derivative 19 began with the conversion of 17b-
[(tert-butyldimethylsilyl)oxy]androst-4-en-3-one 16 to Schiff’s base 17 using boric acid as a catalyst (Scheme 
5). The treatment of compound 17 with dihydrotestosterone afforded thiourea 18. The later compound 18 
was further converted into the desired bis-spiro steroidal β-lactam 19 by treatment with chloroacetyl chloride 
in the presence of triethylamine. The Staudinger-based synthesis of androgen derivative 19 constitutes a 
straightforward procedure in comparison with other methodologies applied in the synthesis of steroid 
derivatives.26  
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Scheme 5 
 
The reaction of imines 23 with chloroacetyl chloride in dimethylformamide yielded the corresponding 
spiro-fused β‐lactam derivatives 24 (Scheme 6). The required imines 23 were prepared by condensation of 
bicycle 22 with nitroso derivatives in dimethylformamide in the presence of piperidine as a catalyst. In turn, 
bicycle 22 was synthesized from 4‐acetyl‐5‐amino‐3‐methyl‐1‐phenyl‐2‐pyrazoline 21 by an intramolecular 
Mannich reaction. Pyrazoline 21 was derived from 4‐acetyl‐5‐imino-3‐methyl-1‐phenyl‐2‐pyrazoline 20 by a 
reductive reaction using Zn/AcOH.27  
Anand and co-workers28 have reported the facile synthesis of axial and equatorial spiro-β‐lactams 26 via 
the entrapment of cyclohexanone imines 25 with acetoxyacetyl chloride in a [2+2]-cyclocondensation at -78°C 
(Scheme 7). The resulting conformations of 4-substituted 1-azaspiro[3.5]nonan-2-ones 26, which could be 
isolated as stable, pure crystals, were confirmed by X-ray crystallography. The restricted conformers were 
kinetically resolved using lipases. The mechanism of spiro-β‐lactam 26 formation was explored using B3LYP/6-
31+G* level quantum chemical calculations.28  
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Scheme 6 
 
 
 
 
Scheme 7 
 
Imines 27, derived from 8-azabicyclo[3.2.1]octan-3-ones, have been shown to be interesting starting 
materials for the synthesis of a new class of β-lactams 28 via Staudinger synthesis with phenoxyacetyl chloride 
(Scheme 8). It is noteworthy that the stereochemical outcome of the obtained spiro-β-lactams (as single 
diastereoisomers) was opposite to the expected products of a [2+2]-cycloaddition reaction, which should have 
taken place from the exo face of compound 27.29 
The Reddy group30 has reported on the synthesis and biological evaluation of a novel series of 
spiroazetidin-2-ones 33 starting from 3-chloro-4-fluoroaniline 29 (Scheme 9). Firstly, the benzothiazole 30 was 
synthesized from 3-chloro-4-fluoroaniline 29 and further condensed with 5-methyl-2-phenylpyrazol-3-one to 
yield the imine 31, which was cyclized with chloroacetyl choride in triethylamine to obtain azetidin-2-one 32. 
Finally, the resulting azetidin-2-one 32 was further condensed with different primary and secondary amines, 
leading to the desired spiro-fused β-lactams 33. These β-lactams 33 exhibited moderate to significant activities 
in anti-inflammatory, anti-diabetic, anti-oxidant and anti-microbial tests.30  
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Scheme 8 
 
 
Scheme 9 
 
In an analogous approach, spiro-[chloroazetidinethiazolopyrimidine] derivatives were obtained by using the 
corresponding thiazolopyrimidine imines.31 
 
2.1.2. Reactions of cyclic ketenes. The utilization of cyclic ketenes in the [2+2]-cyclocondensation with imines 
constitutes an alternative approach for the preparation of spiro-β-lactams.6,32-35 The generation of ketenes by 
the treatment of an acyl chloride with triethylamine is one of the most common methods; however, this 
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approach has sometimes encountered disadvantages such as commercial unavailability, instability and 
difficulties related to the preparation of acid halides.36 To deal with these difficulties, the Zarei and Sardarian 
groups have independently devoted efforts to the preparation of a cyclic ketene from the corresponding 
xanthene-9-carboxylic acid 34 using different carboxylic activators 36 to synthesize spiro-β-lactams 37 by 
Staudinger reaction with imines 35 (Scheme 10, Table 1).15,36-43 The structure of 1-[3-(morpholin-4-yl)propyl]-
4-(3-nitrophenyl)spiro[azetidine-3,9'-xanthen]-2-one - an analog of spiro-β-lactams 37 - was successfully 
determined for the first time by Akkurt via single-crystal X-ray analysis.44 
 
Table 1. Synthesis of spiro-β-lactams 37 using different carboxylic activators 36  
Compounds 36 Compounds 37 (R1, R2) 
 
R1 = C6H5, R
2 = 4-NO2C6H4, 82% 
R1 = 4-EtC6H4, R
2 = 4-NO2C6H4, 87% 
R1 = 4-MeOC6H4, R
2 = 4-MeOC6H4, 85% 
 
R1 = Me, R2 = 4-MeOC6H4, 82% 
R1 = C6H5, R
2 = 4-ClC6H4, 87% 
R1 = 4-MeOC6H4, R
2 = 4-ClC6H4, 85% 
R1 = 4-MeOC6H4, R
2 = 4-MeOC6H4, 85% 
 
R1 = 4-EtOC6H4, R
2 = 4-NO2C6H4, 81% 
R1 = 4-MeOC6H4, R
2 = 4-MeOC6H4, 87% 
R1 = 4-MeOC6H4, R
2 = 4-ClC6H4, 83% 
 
R1 = 4-MeOC6H4, R
2 = 3,4,5-(MeO)3C6H2, 80% 
R1 = 4-EtC6H4, R
2 = 2,4-Cl2C6H3, 84% 
 
R1 = 4-MeOC6H4, R
2 = C6H5, 75% 
R1 = 4-ClC6H4, R
2 = 4-(NMe)2C6H3, 71% 
 
R1 = 4-ClC6H4, R
2 = 4-ClC6H4, 86% 
R1 = 4-ClC6H4, R
2 = 4-(Me2CH)C6H4, 87% 
 
R1 = 4-MeOC6H4, R
2 = 2,4-Cl2C6H3, 72% 
R1 = 4-EtC6H4, R
2 = 3,4,5-(MeO)3C6H2, 70% 
 
R1 = 4-MeOC6H4, R
2 = 4-CH2=CHCOOC6H4 
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Scheme 10 
 
The substituted norbornane carboxylic acids 38 have been used for the formation of the corresponding 
bicyclic norbornane-derived ketenes by a two-step procedure. The cycloaddition of the so-formed ketenes 
with imine 39 led to the generation of diastereomeric norbornane C3-spiro-β-lactams 40, 41, 42, 43 (Scheme 
11, Table 2). It is noteworthy that the stereochemical outcome of spiro-β-lactams 40-43 is influenced by the 
presence of encumbering groups on the cyclic ketenes. In fact, a better selectivity was obtained when methyl 
groups were present near to the carbon bearing the carboxylic functional group. The ratio of diastereoisomers 
was determined by integration of the H-4 proton in the 1H-NMR spectra of the crude reaction mixtures.45 
 
 
Scheme 11 
 
Table 2. Total yields and ratios of spiro-β-lactams 40-43 (a-c)  
Carboxylic 
acids 
X-X R 
Total yield 
(%) 
Diastereomeric ratio (%) 
40 41 42 43 
38a CH=CH H 98 46 27 20 7 
38b CH2-CH2 H 94 53 29 9 9 
38c CH2-CH2 CH3 68 47 53 - - 
 
To study the synthesis of spiro-β-lactam 46 on a larger scale, the reaction of in situ generated ketene from 
compound 44 and imine 45 was conducted in both batch and flow mode (Scheme 12). The reaction outcome 
showed that the Staudinger synthesis in a continuous flow process was deemed a safe method for this highly 
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exothermic reaction. However, the precipitation of generated salts quickly blocked a glass chip and made the 
operation technically impossible.46 
 
 
Scheme 12 
 
Recently, the Mykhailiuk group47,48 has reported on a new approach for the synthesis of 3-substituted 
piperidinyl spiro-β-lactam 51 starting from acid 47 and aldehyde 49 (Scheme 13). In this synthetic approach, 
acid 47 was firstly converted into the corresponding acid chloride and subsequently into ketene 48 by the 
sequential treatment with SOCl2 and NEt(iPr)2. Aldehyde 49 was converted into imine 50 upon treatment with 
LiN(TMS)2. In analogy, a diverse number of spiro-β-lactams attached with 4-, 5-, 6-, 7-membered rings at the C-
3 position were prepared in moderate to good yields. Subsequently, the reductive removal of the carbonyl 
group of spiro-β-lactam analogs 51 was conducted by the reducing reagent AlH3 giving the corresponding 
spirocyclic azetidines, which were investigated further in drug design and as an analog of the anesthetic drug 
bupivacaine.47,48  
 
 
 
Scheme 13 
 
2.2. Cyclization reactions 
A convenient entry toward the construction of spirocylic β-lactams comprises the cyclization of β-amino acid 
derivatives and β-functionalized amides.13 In that respect, Zhang and co-workers49 have developed novel 
synthetic routes to produce several spiro-4-cyclohexadienonyl-β-lactams 53 from N-(4-hydroxyphenyl)-3-
oxopropanamides 52 through dearomatization and cyclization processes with iodobenzene diacetate (IBD) as 
oxidant in the presence of a stoichiometric amount of copper(II) sulfate pentahydrate and 4-dimethylamino-
pyridine (DMAP).49 Later, this method was modified by using only a catalytic amount of copper(II) sulfate 
pentahydrate and 4-dimethylaminopyridine (DMAP), which gave similar yields (Scheme 14).50  
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Scheme 14 
 
In addition, this modification also allowed for the synthesis of a diverse number of spiro-4-
cyclohexadienone-β-lactams 55 with cyclopentanone, γ-lactone, and γ-lactam side chains on their C3 position, 
starting from the corresponding amides 54 (Scheme 15).50 
 
 
Scheme 15 
 
Furthermore, the replacement of copper(II) sulfate pentahydrate by [Cu3((S)-PIA)2(1,4-
dioxane)(H2O)2]2(1,4-dioxane)H2O (L-1) has been shown to be equally effective in the preparation of spiro-4-
cyclohexadienonyl-β-lactam analogs.51 
In independent research, Xu has described the synthesis of 4-spiro-cyclohexadienonyl-β-lactam-3-carbo-
nitriles 57 by means of the intramolecular nucleophilic cyclization of N-(p-hydroxyphenyl)cyanoacetamides 56 
with iodobenzene diacetate (IBD) as oxidant and potassium hydroxide as base (Scheme 16).10 
 
 
Scheme 16 
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The cyclization of Dab-derived (Dab = 2,4-diaminobutanoic acid) chloroacetyl compound 59, which was 
obtained in a quantitative yield by treatment of compound 58 with chloroacetyl chloride in the presence of 
propylene oxide, gave rise to 1,6-diazaspiro[3.4]octane-2,5-dione 60 (Scheme 17). The construction of 
spirocylic β-lactam 60 could be explained by the concomitant formation of the β-lactam and pyrrolidinone 
ring, the latter due to a 5-exo-trig ring closure between the ZNH group and the carboxylic ester, followed by Z-
protecting group removal.52 
 
 
 
Scheme 17 
 
In the course of a study on proline-like compounds with potential biological interest, Ponticelli and co-
workers53 have devised an approach toward the synthesis of functionalized spiro-pyrrolidine 63 (Scheme 18). 
In particular, treatment of pyrrolidine aldehyde 61 with the reducing reagent NaCNBH3, together with methyl-
amine, gave rise to the β-amino ester 62. Subsequently, the cyclization of compound 62 using two equivalents 
of the strong base LDA led to the desired spiro-β-lactam 63.53 In independent research, Sharada and co-
workers have also described an effective synthesis of a pyrrolidine-derived spiro-β-lactam starting from 
natural proline.54 
 
 
 
Scheme 18 
 
The Grainger group55 has published the preparation of a spirocyclic β-lactam by using a 4-exo-trig 
carbamoyl radical cyclization approach. Specifically, amine 64, prepared in one step by reductive amination of 
commercially available 1-cyclohexene-1-carboxaldehyde with p-methoxyaniline,11 was converted into the 
carbamoyl radical precursor 65 (Scheme 19). Then, irradiation of compound 65 with a 500 W halogen lamp 
afforded spirocyclic dithiocarbamate 66 as a single diastereomer. The stereochemistry of compound 66 was 
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determined by NOE spectral analysis, which showed the proton adjacent to sulfur to be on the same side of 
the cyclohexyl ring as the methylene group of the β-lactam. The reduction of 66 with H3PO2-ACCN successfully 
gave spirocyclic β-lactam 67.55 
 
 
 
Scheme 19 
 
Spiro-β-lactam 75 has been synthesized as an intermediate compound in an effort to find drugs to 
improve hepatitis C virus (HCV) therapy (Scheme 20).56 1,2-Bis(bromomethyl)benzene 68 was condensed with 
diethyl malonate 69, furnishing a crude diethyl malonate derivative. This derivative was reacted with sulfuric 
acid in the presence of methanol at 200 °C, giving methyl ester 70. Treatment of ester 70 with LDA afforded 
the corresponding enolate, which was trapped with TMSCl leading to silyl enol ether 71. Reaction of generated 
enol 71 with N-p-methoxyphenyl (PMP) imine 72 in the presence of TMSOTf gave compound 73 as a mixture 
of enantiomers. Cyclization of compound 73 with MeMgBr gave rise to spiro compound 74 in 70% yield. 
Removal of the PMP group of spiro-β-lactam 74 with CAN led to the desired compound 75.56  
 
 
 
Scheme 20 
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Indolenine β-lactams 77, present as key moieties in the complete structure of chartellines, were 
synthesized by an intramolecular nucleophilic substitution initiated by indolenine derivatives 76 using LiHMDS 
as a base (Scheme 21).57  
 
 
 
Scheme 21 
 
A highly regioselective intramolecular amination of an sp3 carbon in amide derivatives bearing an 8-
aminoquinolinyl group as the bidentate directing group using transition metal catalysts has recently attracted 
considerable attention of different research groups.58-63 The intramolecular dehydrogenative cyclization of 
aliphatic amides 78 afforded spiro-β-lactams 79 by utilizing a bidentate chelation and various oxidants in 
combination with copper, nickel and cobalt catalysts (Scheme 22). The formation of β-lactams was proposed 
to proceed in all cases via C-N bond-forming reductive elimination.63 
 
 
 
Scheme 22 
 
The direct C-H cyclization of amides 80 bearing five-, six- and seven-membered rings proceeded via in situ 
iodonium ylide formation 80” without the assistance of a transition metal, delivering the corresponding spiro-
β-lactams 81 in a single step (Scheme 23). From a mechanistic point of view, this transformation is consistent 
with the facile formation of a reactive singlet carbene. However, it circumvents the classical use of diazo 
substrates for C-H insertion chemistry.64 
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Scheme 23 
 
Phototransformation chemistry has demonstrated a great potential for challenging building block 
synthesis. In that regard, the irradiation (direct excitation at ~350 nm or triplet sensitization with thioxanthone 
at ~420 nm) of atropisomeric enones 82 gave rise to the corresponding spiro-β-lactam photoproducts 83 (as 
major products) and 84 (as minor products) (Scheme 24). Computational investigation revealed that the 
presence of an ortho-tert-butyl substituent on atropisomeric enones 82 prevented the 6π-photocyclization to 
undergo an efficient hydrogen abstraction leading to atropselective spiro-β-lactam formation.65,66 
 
 
 
Scheme 24 
 
Cyclization of propiolamide 85 with triphenylphosphine as a catalyst in ethanol under reflux furnished the 
corresponding spiro-3-methyleneazetidin-2-one 86 in a moderate yield (Scheme 25). The rather low yield of 
spiro-β-lactam 86 might be rationalized by the steric hindrance experienced in the 4-exo cyclization step.67 
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Scheme 25 
 
Several methods based on C(sp3)-H activation using Pd as a catalyst have recently been introduced to 
access a wide variety of ring systems.68-70 Boudoin and co-workers have described the utilization of carbamoyl 
chlorides 87 as appropriate substrates to construct spirocyclic β-lactams 88 through Pd-catalyzed C(sp3)-H 
activation under both CO balloon and COgen (solid CO-releasing molecules) conditions (Scheme 26).71 
 
 
 
Scheme 26 
 
2.3. Transformations of substituents connected to monocyclic azetidin-2-ones 
One of the most convenient methodologies for the preparation of spiro-fused β-lactams concerns the 
deployment of substituents on monocyclic azetidin-2-ones. In that respect, the Benito group has recently 
reported on the synthesis of spirocyclic seleno-β-lactams 90 from azetidin-2-one-tethered allenols 89 and the 
selenenylating reagent N-phenylselenophthalimide (NPSP) via ring enlargement (Scheme 27).72 
 
 
 
Scheme 27 
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In addition, this group has disclosed a diastereoselective synthesis of spirocyclic β-lactam derivative (-)-92 
starting from optically pure azetidine-2,3-dione (+)-91 applying Passerini reaction conditions with bromoacetic 
acid and benzyl isocyanide, followed by the addition of the non-nucleophilic base N,N'-diisopropylethylamine 
(DIPEA) (Scheme 28).73 
 
 
 
Scheme 28 
 
6-Diazopenicillanates 94 have been obtained in high yields by the combination of 6-β-aminopenicillanates 
93 with ethyl nitrite at room temperature. Then, these 6-diazopenicillanates 94 were subjected to 
stereoselective 1,3-dipolar cycloaddition with acrylonitrile, acrylates and methyl vinyl ketone, giving the 
corresponding spiro-2-pyrazoline-β-lactam derivatives 95, 96 and 97 as major products (Scheme 29). It should 
be noted that the 1,3-dipolar cycloaddition was stereoselective, the major cycloadduct being the result of the 
dipolarophile addition to the less sterically hindered α-side of the β-lactam.74 
 
 
 
Scheme 29 
 
In analogy, chiral spiropyrazolinepenicillanates 101, 102 and 103 were obtained in a stereoselective 
fashion via 1,3-dipolar cycloaddition of 6-alkylidenepenicillanates 100, prepared through Wittig reaction of the 
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appropriate benzhydryl 6-oxopenicillanate 98 and phosphorus ylides 99, with the corresponding 
diphenyldiazomethane, diazomethane and phenyldiazomethane (Scheme 30).75 
 
 
 
Scheme 30 
 
In another study, the use of 10 mol% copper(II) acetate monohydrate as a catalyst and air as the 
stoichiometric re-oxidant enabled the synthesis of spirocyclic oxindole β-lactam 105 via the cyclization of 
precursor 104 using mesitylene as the solvent (Scheme 31).12,76-78 
 
 
 
Scheme 31 
 
Halocyclization of seleno- or thio-substituted β-lactams containing a carbon-carbon multiple bond 
concerns one of the pioneering methods for synthesis of halogenated 4-pyrazolyl spirocyclic-β-lactams.79-81 
Bhalla has recently reported on the synthesis of halogenated 4-pyrazolyl spirocyclic-β-lactams 107-110 via 
halogen-mediated intrasulfenyl cyclization of cis-3-propynyloxy-4-pyrazolyl-β-lactams 106 (Scheme 32). The 
effect of halogenating reagents and selectivity on the formation of the product has been carefully considered. 
These novel spiro-β-lactams 107-110 have been submitted for molecular docking studies and in vitro 
evaluation for biological activity.80 
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Scheme 32 
 
The optically active α-methylene-β-lactam (S)-111 has been subjected to cyclopropanation with CH2N2 in 
CH2Cl2 and [3+2]-cycloaddition with diphenylnitrone, giving rise to the corresponding cyclopropane derivative 
(S)-112 in 85% yield and spiroisoxazolidine adduct (3S, 4S, 7S)-113 in 92% yield, respectively (Scheme 33).82 
 
 
 
Scheme 33 
 
Recently, the deployment of 3-methylene-4-(trifluoromethyl)azetidin-2-ones 112 as versatile building 
blocks allowed access to novel spiro-fused β-lactam systems. In particular, 1,3-dipolar nitrone-olefin 
cycloaddition of 3-methylene-β-lactams 112 with either N-phenyl- or N-tert-butyl-α-phenylnitrone gave 3-
trifluoromethyl-5-oxa-2,6-diazaspiro[3.4]octan-1-ones 113 (Scheme 34). In addition, CF3-substituted 
spirocycles 115 and 116 were prepared upon treatment of the corresponding diols 114, derived from the 
OsO4-mediated oxidation of 3-methylene-β-lactams 112, with pTsOH in 2,2-dimethoxypropane and with 
triphosgene, respectively (Scheme 34).83,84 
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Scheme 34 
 
Recently, Li and co-workers85 have developed a facile access to a broad range of trifluoromethyl-
containing spirocyclic β-lactams via cycloaddition of α-methylene-β-lactams 117 with CF3CHN2 118, which was 
generated in situ from 2,2,2-trifluoroethylamine hydrochloride and NaNO2 (Scheme 35). Under metal-free 
conditions, [3+2]-cycloaddition of α-methylene-β-lactams 117 with CF3CHN2 led to 2-pyrazoline-containing 
spirocyclic β-lactams 119 as single diastereomers in good to high yields (82–96%). On the other hand, the use 
of an iron catalyst (FeTPPCl) gave rise to cyclopropane-containing spirocyclic β-lactams 120 with good 
diastereoselectivity. The resulting spirocyclic β-lactams bearing a CF3 moiety are considered to be useful 
scaffolds for drug discovery and their further exploration in terms of biological activities.85  
 
 
 
Scheme 35 
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2.4. Other methods 
The reductive Mannich-type reaction of α,β-unsaturated ester 121 with imine 122 using a Rh catalyst and 
Et2Zn provided a rapid access to spiro-β-lactam 123 (Scheme 36). A mechanism was proposed involving the 
formation of the rhodium−hydride complex (Rh-H) due to combination of Et2Zn and RhCl(PPh3)3. 
Subsequently, this complex catalyzed the 1,4-reduction of α,β-unsaturated esters, resulting in a rhodium 
enolate as a Reformatsky-type reagent. In the end, this enolate reacted with imine 122, giving rise to spiro-β-
lactam 123.86 In addition, the Willcox group has described the synthesis of an analog of spiro-β-lactam 123 by 
an aliphatic amine C–H carbonylation process catalyzed by Pd.87  
 
 
 
Scheme 36 
 
The Bruce group has recently published the synthesis of spirocyclic β-lactams 126 through a palladium-
catalyzed multicomponent method, including participation of imines 125, ortho-iodo-substituted aryl imines 
124 and CO (Scheme 37). The structure of the resulting spirocyclic β-lactams, bearing a trans orientation of the 
aromatic units, was confirmed by NOE and X-ray analysis.88 
 
 
 
Scheme 37 
 
Recently, Enders and co-workers have investigated a novel approach utilizing a copper-catalyzed 
Kinugasa/Michael domino reaction of alkyne-tethered cyclohexadienones 127 and nitrones 128, providing 
unprecedented spirocyclic β-lactams 129 in good yields with excellent stereoselectivities (Scheme 38).89  
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Scheme 38 
 
3. Reactivity of Spiro-fused β-lactams 
 
Along with efforts to improve synthetic methodologies, the deployment of spiro-fused β-lactams as interesting 
synthons to construct complex heterocycles has also been explored. The reactivity of spiro-fused β-lactams is 
related to the nature of these four-membered cyclic amides and the presence of substituents on the ring. In 
this section, the behavior of spiro-fused β-lactams toward ring-opening and ring-transformation reactions will 
be considered. 
 
3.1. Ring-opening reactions 
In general, spiro-fused azetidin-2-ones often suffer from ring-opening reactions upon treatment with various 
acids, bases, reducing reagents and oxidative reagents.13 However, the treatment of 1-substituted spiro-fused 
β-lactams 130 with the reducing reagent LiAlH4 resulted in the unanticipated 3-benzhydryl-1-methylindole 131 
as the major product, accompanied by a small amount of the ring-opening product 3-(2-hydroxy-1,1-
diphenylethyl)-3-(4-methoxyphenylamino)-1-methylindolin-2-ol 132 (Scheme 39). Furthermore, the cleavage 
of N1-C4 and C3-C4 bonds of azetidin-2-ones 130 has been investigated upon treatment with the oxidising 
reagent CAN.90 
 
 
Scheme 39 
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The employment of a Lewis–Brønsted acid in combination with a superacid catalyst system promoted a 
regiospecific N1-C2 ring-opening reaction of N-aryl-3-spirocyclic-β-lactams 133 followed by a recyclization, 
providing an efficient entry to 3-spirocyclic quinolin-4(1H)-ones 134 in good to high yields (Scheme 40).91 
 
 
 
Scheme 40 
 
The norbornane-derived spiro-β-lactams 40-41b have been subjected to acid hydrolysis (HBr), giving rise 
to the corresponding norbornane-derived β-amino acids 135 and 136 (Scheme 41).45 
 
 
 
Scheme 41 
 
The activation of spiro-β-lactam 141 with di-tert-butyl dicarbonate and subsequent intermolecular 
nucleophilic ring opening upon treatment with DBU/MeOH afforded 2-oxopiperidino-β-amino ester 142 in 
excellent yield (Scheme 42). The preparation of spiro-β-lactam 141 was performed starting from β-lactam 138, 
which was synthesized from ornithine derivative 137 via a three-step procedure. Accordingly, the removal of 
the Z protecting group from 138 by catalytic hydrogenation resulted in the formation of the 3,5-spiro-
derivative 139 in good yield, through a 6-exo-trig ring closure. The resulting spiro-β-lactam 139 reacted with 
benzyl bromide, furnishing the 1-benzyl derivative 140 in an almost quantitative yield. Treatment of 
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compound 140 with CAN led to the removal of the p-methoxyphenyl group, yielding the N-deprotected spiro-
β-lactam 141.92 
 
 
 
Scheme 42 
 
Also relevant to this section is the fact that, during the course of preparing nylon-3 materials bearing 
diverse appended functionalities, Gellman and co-workers have recently reported the ring-opening 
polymerization of spiro-β-lactams generating nylon-3 homo- or co-polymers.93 
 
3.2. Ring-transformation reactions of substituents attached to the ring carbon atoms 
Thermolysis of spiro-β-lactam-oxadiazolines 143 to generate β-lactam carbenes 144 has attracted the 
attention of several research groups because of the important synthetic applications of the resulting carbenes 
for the construction of novel mono-, spiro- or polyheterocyclic compounds.94 For example, the reaction of β-
lactam carbenes 144 with 3,6-diphenyl-, 3,6-di(2-pyridyl)-, 3,6-di(2-thienyl)-, 3,6-di(4-pyridyl)-1,2,4,5-
tetrazines and 3,6-di-(2-pyrimidinyl)tetrazines readily afforded various aryl-fused cyclopenta[b]pyrrol-2-one 
derivatives in high yields.32,95-99 Recently, Wang has reported on the use of β-lactam carbenes 144 to produce 
a novel series of 5-triazolo[1,5-a]pyrazinepyrrol-2-ones 146 in a one-pot mechanism (Scheme 43). These 5-
triazolo compounds can emit light both in solution and in a solid state, with emission peaks at 77K and in solid 
state, showing an obvious blue-shift.94 
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Scheme 43 
 
The ring contraction of spiro-1-pyrazoline-β-lactams 97 via microwave-induced denitrogenation gave rise 
to a mixture of spirocyclopropylpenicillanates 147 and 148 (Scheme 44).74,75 
 
 
Scheme 44 
 
The reduction of spiro-β-lactams by different reducing reagents (AlH3, AlClH2, LiAlH4 …) comprises one of 
the most convenient methodologies to generate the corresponding spirocyclic azetidines, which have been 
applied in drug design.46,48,56 For instance, the reduction of the amide group in compound 51 with AlH3 
afforded spirocyclic azetidine 149 in 92% yield (Scheme 45), which can indeed be seen as a promising building 
block for the preparation of complex molecules.48 Careful monitoring of the reaction is usually required to 
avoid reductive β-lactam ring opening. 
 
 
Scheme 45 
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Furthermore, spiro-β-lactam 150 has been subjected to enolization using KHMDS in THF, and subsequent 
treatment of the enolate with Davis oxaziridine 151 or isoamyl nitrite led to the corresponding α-hydroxy 
lactam 152 or oxime 155 in high yields, respectively (Scheme 46). Then, the β-lactams 152 and 155 were 
successfully reduced using monochloroalane to give spirocyclic azetidines 153 and 156, respectively. The 
azetidin-3-ol 153 was further converted to the corresponding ketone 154 under Swern oxidation conditions.100 
 
 
Scheme 46 
 
4. Bioactive Spiro-fused β-lactams 
 
Spiro-β-lactams constitute an interesting class of bioactive compounds possessing a wide spectrum of 
activities, such as antibacterial, antiviral and antimicrobial effects. In addition, the use of spiro-β-lactams as β-
lactamase and cholesterol absorption inhibitors or synthetic intermediates for β-turn mimics and β-turn 
nucleators, has been documented.11-13,74,101 In this section, a brief selection of renewed pharmacological 
applications of spiro-β-lactam systems will be considered.  
 
 
 
Figure 2. Bioactive spiro-fused β-lactams. 
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The new spiro-β-lactams 2 and dispiro-β-lactams 3 have been demonstrated to exhibit good to excellent 
antimalarial activities against chloroquine-resistant Plasmodium falciparum K14 strain with IC50 varying from 5 
to 32.2 mM.14 The spirocyclic β-lactam 157 (Figure 2), supported on superparamagnetic Fe3O4@SiO2 nano-
particles, enhanced the antibacterial activity in comparison with the corresponding spirocyclic β-lactam, which 
was supposed to be due to the synergic effect of the Fe3O4@SiO2/β-lactam combination.
102,103  
A number of novel spiro[azetidine-2,3'-indole]-2',4(1'H)-dione derivatives have been tested for anti-breast 
cancer activity, however, only 3-chloro-1-(o-tolyl)spiro[azetidine-2,3'-indoline]-2',4-dione 158 (Figure 2) 
displayed a significant cytotoxicity (IC50 = 22.75-25.18 μM) for breast cancer cell lines after 48 h, which is 
comparable to the standard control drug doxorubicin.104 
Recently, ((2S,3R)-3-hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro[3.4]octan-2-yl)butanamide) 159 
(Figure 2) has been examined for in vitro and in vivo pharmalogical properties. This compound appeared to be 
a novel N-methyl-D-aspartate (NMDA) receptor-specific modulator that facilitates synaptic plasticity and has 
therapeutic potential for a variety of NMDA receptor-mediated central nervous system (CNS) disorders.105,106 
 
 
5. Conclusions 
 
In conclusion, the potential pharmacological activities, along with significant synthetic applications of 
spirocyclic β-lactams, have given a fresh impetus to synthetic chemists to design novel spiro-β-lactam 
structures. Synthetic approaches toward spirocyclic β-lactams, including the Staudinger ketene-imine 
cyclocondensation, the cyclization of β-amino acids and β-functionalised amides and transformation reactions, 
have been improved in recent years (e.g., increase yield and stereoselectivity of reactions as well as the use of 
greener reaction conditions) and have been intensively discussed in this review. In view of their interesting 
chemical and biological properties, spirocyclic β-lactams are expected to attract considerable attention in the 
future as well.  
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